Egetis Therapeutics AB (publ) (STO:EGTX)
5.34
+0.06 (1.14%)
At close: Dec 30, 2025
Revenue by Product
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Revenue by Geography
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.